- Puma to host investor/analyst meeting and webcast on June 1 -
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a development stage
biopharmaceutical company, announced the release of four abstracts on
its drug candidate PB272 (neratinib) that will be presented at the
American Society of Clinical Oncology (ASCO) Annual Meeting, which will
be held May 29 to June 2, 2015, in Chicago. Abstracts are available to
the public online on the ASCO website: www.abstract.asco.orgmore...